Joanne Beck, Ph.D.

Chief Technical Officer

Joanne Beck is a seasoned biotech executive with over 30 years of experience across large pharma and early-stage biotech in the areas of CMC, product development, clinical & commercial manufacturing, and supply chain. Over the course of her career, she has contributed to the licensure and commercialization of numerous medicines across modalities and therapeutic areas, including cell and gene therapy and immunology.

Before Abata, Joanne most recently served as the chief technology officer at Aerium Therapeutics, Inc. Prior to Aerium, she was the chief operating officer and interim CEO at Boston Pharmaceuticals. Previously, Joanne served as the Executive Vice President of Global Pharmaceutical Development and Operations at Celgene Corporation. While at Celgene, she was responsible for much of the groundwork leading to one of the first cell therapy approvals. Joanne also served in leadership positions at other pharmaceutical and biotech companies, including Shire, Abbott Laboratories, Amgen, and Genentech. She has served as a member of the board of directors of public biopharmaceutical companies, including Orchard Therapeutics and Astria Therapeutics.

Joanne holds a Ph.D. in Biochemistry and Molecular Biology from Oregon Health and Science University and completed a postdoctoral fellowship in the department of Pharmaceutical Chemistry at the University of California, San Francisco.

Back to all posts